T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas
Edith Willscher,
Christoph Schultheiß,
Lisa Paschold,
Franziska Lea Schümann,
Paul Schmidt-Barbo,
Benjamin Thiele,
Marcus Bauer,
Claudia Wickenhauser,
Thomas Weber,
Mascha Binder
Affiliations
Edith Willscher
Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle
Christoph Schultheiß
Department of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel
Lisa Paschold
Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle
Franziska Lea Schümann
Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle
Paul Schmidt-Barbo
Department of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel
Benjamin Thiele
Department of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel
Marcus Bauer
Department of Pathology, Martin-Luther-University Halle-Wittenberg, Halle
Claudia Wickenhauser
Department of Pathology, Martin-Luther-University Halle-Wittenberg, Halle
Thomas Weber
Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle
Mascha Binder
Department of Biomedicine, Translational Immuno-Oncology, University of Basel, Basel, Switzerland; Division of Medical Oncology, University Hospital Basel, Basel
While T cell lymphomas are classified as mature neoplasms, emerging evidence indicates that malignant transformation may occur at an earlier stage of T cell maturation. In this study, we determined clonal architectures in a broad range of T cell lymphomas. Our multidimensional profiling indicates that a large part of these lymphomas in fact emerge from an immature lymphoid T cell precursor at a maturation stage prior to V(D)J rearrangement that undergoes branching evolution. Consequently, at single cell resolution we observed considerable clonal tiding under selective therapeutic pressure. T cell receptor next-generation sequencing suggested a highly biased usage of TRBV20-1 gene segments as part of multiple antigen receptor rearrangements per patient. The predominance of TRBV20-1 was found across all major T cell lymphoma subtypes analyzed. This suggested that this particular V gene – independently of complementarity-determining region 3 (CDR3) configuration - may represent a driver of malignant transformation. Together, our data indicate that T cell lymphomas derive from immature lymphoid precursors and display considerable intratumoral heterogeneity that may provide the basis for relapse and resistance in these hard-to-treat cancers.